CANO

Concerned Shareholders of Cano Health Issue Letter Regarding its Commitment to Turning Around the Company

Retrieved on: 
Friday, June 2, 2023

As outlined in the subsequent sections of this letter, we have a deep understanding of the challenges at Cano and possess a clear vision for turning around the Company.

Key Points: 
  • As outlined in the subsequent sections of this letter, we have a deep understanding of the challenges at Cano and possess a clear vision for turning around the Company.
  • Our Group has thought critically about how Cano can evolve from being a founder-dominated business to a mature, well-governed company.
  • This will help improve morale and ultimately employee retention, which has been a significant issue for Cano over the past 18 months.
  • In our view, this “Shadow Board” precluded our Group from discharging our fiduciary duties and participating in the oversight of the Company.

Concerned Shareholders of Cano Health Issue Presentation to Underscore the Urgent Need for Changes in Leadership and Strategy Following Massive Value Destruction at the Company

Retrieved on: 
Tuesday, May 30, 2023

Dr. Muney and Ms. Rivera are also members of Cano’s Audit Committee.

Key Points: 
  • Dr. Muney and Ms. Rivera are also members of Cano’s Audit Committee.
  • DOWNLOAD AND READ THE GROUP’S PRESENTATION BY CLICKING HERE.
  • Messrs. Berardo and Sansone possess significant healthcare services experience as well as backgrounds in corporate governance, capital allocation, transactions and strategic planning.
  • The action seeks to compel Cano to reopen the window for nominating director candidates and making proposals under the Company’s Bylaws at the upcoming Annual Meeting.

Concerned Shareholders of Cano Health File Definitive Proxy Statement to Solicit Votes Against the Company’s Two Entrenched Director Candidates

Retrieved on: 
Thursday, May 25, 2023

As Chair of the Compensation Committee, Dr. Muney has established a “pay for failure” culture and presided over the issuance of excessive equity awards.

Key Points: 
  • As Chair of the Compensation Committee, Dr. Muney has established a “pay for failure” culture and presided over the issuance of excessive equity awards.
  • These critiques are merely an overview of the troubled track records that both individuals have amassed while on the Board.
  • The action seeks to compel Cano to reopen the window for nominating director candidates and making proposals under the Company’s Bylaws at the upcoming Annual Meeting.
  • The Group has filed a proxy statement to solicit stockholders to WITHHOLD support for incumbent directors standing for re-election at Cano’s Annual Meeting.

Concerned Shareholders of Cano Health Issue Open Letter Regarding the Board’s Entrenchment Maneuvers and Latest Governance Failures

Retrieved on: 
Wednesday, April 26, 2023

Further, the Company’s recent press releases are full of misleading information and ignore the pressing issues on the minds of shareholders.

Key Points: 
  • Further, the Company’s recent press releases are full of misleading information and ignore the pressing issues on the minds of shareholders.
  • In our view, all shareholders should take note of the following points:
    We believe the appointment of Mr. Trujillo as Chairman represents a self-interested entrenchment maneuver and slap in the face to concerned shareholders.
  • Mr. Trujillo’s unwarranted elevation is yet another slap in the face to Cano shareholders, whose questions regarding conflicts, related-party transactions and oversight of management remain unanswered.
  • We look forward to continuing to advocate for the best interests of Cano and all of its shareholders.

Cano Health Announces Date to Report First Quarter 2023 Results

Retrieved on: 
Tuesday, April 25, 2023

MIAMI, April 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.

Key Points: 
  • MIAMI, April 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.
  • To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health First Quarter 2023 Earnings Conference Call and Conference ID 8371699.
  • The call will also be webcast live in the "Events & Presentations" section of Cano Health's investor relations website ( investors.canohealth.com ).
  • A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call and will be available for 30 days.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Long-Term Holders of Cano Health (CANO) Shares to Contact Firm, Firm Investigating Possible Breach of Fiduciary Duty Claims Against Board

Retrieved on: 
Monday, April 17, 2023

Hagens Berman is investigating whether Cano’s directors may have breached their fiduciary duties owed to the company.

Key Points: 
  • Hagens Berman is investigating whether Cano’s directors may have breached their fiduciary duties owed to the company.
  • 31, 2023, an early Cano investor and board member (Barry Sternlicht) issued a statement announcing his resignation from Cano’s board effective immediately.
  • If you are a long-term holder of Cano Health shares, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Cano Health should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

Award Winning Firm Labaton Sucharow Investigating Cano Health Inc. – CANO

Retrieved on: 
Monday, April 17, 2023

Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities law violations and breach of fiduciary duty claims against Cano Health Inc. (NYSE: CANO).

Key Points: 
  • Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities law violations and breach of fiduciary duty claims against Cano Health Inc. (NYSE: CANO).
  • If you currently own stock or options in Cano Health Inc. and suffered a loss, click here to contact Labaton Sucharow to discuss your options .
  • If you want to receive additional information and protect your investments free of charge, please contact Labaton Sucharow’s shareholder rights team via email at [email protected] or calling (212) 907-0759.

Concerned Shareholders of Cano Health Urge Company to Reopen Window for Nominating Director Candidates at 2023 Annual Meeting

Retrieved on: 
Monday, April 17, 2023

We believe that significantly more than a majority of the shareholder base already supports our case for urgent change.

Key Points: 
  • We believe that significantly more than a majority of the shareholder base already supports our case for urgent change.
  • In the face of such significant dissatisfaction, we believe it is imperative that the Board take immediate steps to heed the will of shareholders.
  • That is why we have sent a letter to the Board demanding that it reopen the window for the nomination of director candidates and making of other proposals at the 2023 Annual Meeting of Stockholders (the “Annual Meeting”).
  • While we would typically respect the bylaw provisions around the timing of nominations and proposals, this is an extremely unique situation that justifies extraordinary action.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Long-Term Holders of Cano Health (CANO) Shares to Contact Firm, Firm Investigating Possible Breach of Fiduciary Duty Claims Against Board

Retrieved on: 
Friday, March 31, 2023

SAN FRANCISCO, March 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges long-term holders of Cano Health, Inc. (NYSE: CANO) to contact the firm now .

Key Points: 
  • SAN FRANCISCO, March 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges long-term holders of Cano Health, Inc. (NYSE: CANO) to contact the firm now .
  • Hagens Berman is investigating whether Cano’s directors may have breached their fiduciary duties owed to the company.
  • 31, 2023, an early Cano investor and board member (Barry Sternlicht) issued a statement announcing his resignation from Cano’s board effective immediately.
  • If you are a long-term holder of Cano Health shares, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

Concerned Shareholders of Cano Health Issue Open Letter Regarding the Urgent Need for Leadership and Strategy Changes at the Company

Retrieved on: 
Monday, April 10, 2023

Given our backgrounds, as well as our sizable investment, we hope it is clear that we are squarely aligned with all Cano shareholders.

Key Points: 
  • Given our backgrounds, as well as our sizable investment, we hope it is clear that we are squarely aligned with all Cano shareholders.
  • In the subsequent sections of this letter, we provide an overview of our concerns and ideas, including:
    The urgent need for C-suite and boardroom changes at Cano.
  • The path to establishing the right corporate governance and the right, value-enhancing strategy for Cano.
  • We are eager to hear if other shareholders share our views on the best path forward for Cano, as outlined in this letter.